title: Vasopressin deficiency in primary nocturnal enuresis. Results of a controlled prospective study.
abstract: The lack of circadian rhythmicity of plasma arginine vasopressin (AVP) in primary nocturnal enuresis (PNE) in some children is known. The original test protocol is time-consuming and needs excellent compliance by children and parents. The goals of the presented study are the introduction of a simple screening test and the evaluation of the response of treatment using intranasal synthetic vasopressin. Fifty-five children (aged 8.2 +/- 3.1 years) with PNE and 15 children (aged 7.9 +/- 2.4 years) of a control group were investigated. Using a standardized protocol, AVP levels were measured by radioimmunoassay (RIA) under controlled water intake 3 times per day over a period of 72 h. Fourteen of 55 tested children (25.5%) with PNE had a significant decrease in nocturnal AVP when compared to the control group. We measured also an increased nocturnal urine volume and a lower urine osmolality in this enuretic group. Eight of 14 patients (57.1%) with plasma AVP deficiency (AVPD) also had bladder instability. Nine of 14 patients (64.3%) with AVPD with or without concomitant bladder instability were totally dry during desmopressin treatment, but only 2 (14.3%) remained dry after discontinuation of treatment. Our data suggest that nocturnal urine osmolality measurement may reflect AVPD and predict a positive treatment outcome.
authors.affiliation: Department of Urology, University of Saarland, Homburg, FRG.
authors.forename: J
authors.initials: J
authors.lastname: Steffens
authors.forename: M
authors.initials: M
authors.lastname: Netzer
authors.forename: E
authors.initials: E
authors.lastname: Isenberg
authors.forename: S
authors.initials: S
authors.lastname: Alloussi
authors.forename: M
authors.initials: M
authors.lastname: Ziegler
mesh_terms: D000281:Administration, Intranasal; D001127:Arginine Vasopressin / Q000172:deficiency*; D002648:Child; D002940:Circadian Rhythm; D003894:Deamino Arginine Vasopressin / Q000008:administration & dosage; D004775:Enuresis / Q000097:blood* / Q000188:drug therapy / Q000503:physiopathology / Q000652:urine; D005260:Female; D006801:Humans; D008297:Male; D009994:Osmolar Concentration; D011446:Prospective Studies; D014563:Urodynamics
chemical_list: D001127:Arginine Vasopressin; D003894:Deamino Arginine Vasopressin